0.157 USD
-0.02 (-13.16%)
0.1565 USD
0 (-0.32%)
ChartMill assigns a Buy % Consensus number of 84% to MDNA. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 2.88. This target is 1735.48% above the current price.
MDNA was analyzed by 11 analysts. The buy percentage consensus is at 84. So analysts seem to be very confident about MDNA.
In the previous month the buy percentage consensus was at a similar level.
MDNA was analyzed by 11 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-12-06 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-08-14 | Oppenheimer | Maintains | Outperform -> Outperform |
| 2023-08-10 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-07-31 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-06-28 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-02-08 | HC Wainwright & Co. | Reiterate | Buy |
| 2022-11-08 | HC Wainwright & Co. | Maintains | Buy |
| 2022-08-16 | HC Wainwright & Co. | Maintains | Buy |
| 2022-06-23 | Oppenheimer | Maintains | Outperform |
| 2022-06-23 | HC Wainwright & Co. | Maintains | Buy |
MEDICENNA THERAPEUTICS CORP / MDNA FAQ
Can you provide the average price target for MEDICENNA THERAPEUTICS CORP stock?
11 analysts have analysed MDNA and the average price target is 2.88 USD. This implies a price increase of 1735.48% is expected in the next year compared to the current price of 0.157.
What is the consensus rating for MDNA stock?
The consensus rating for MEDICENNA THERAPEUTICS CORP (MDNA) is 83.6364 / 100 . This indicates that analysts generally have a positive outlook on the stock.